Showing results (531-540 of 1,014) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|March 16, 2023
Depletion of Mannose Receptor-Positive Tumor-associated Macrophages via a Peptide-targeted Star-shaped Polyglutamate Inhibits Breast Cancer Progression in MiceAnni Lepland, Alessio Malfanti, Uku Haljasorg, et al.Cancer Research Communications|February 24, 2023
Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with CancerDuncan R McKenzie, Rosalind Graham, Thomas Lechmere, et al.Cancer Research Communications|March 27, 2023
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP InhibitionKunzah Jamal, Alessandro Galbiati, Joshua Armenia, et al.Cancer Research Communications|March 27, 2023
Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant CellsMatthew J Martin, Nicolas Floc'h, Matthias Pfeifer, et al.Cancer Research Communications|March 27, 2023
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair DefectsMansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, et al.Cancer Research Communications|March 27, 2023
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal AdenocarcinomaEric S Christenson, Su Jin Lim, Jennifer Durham, et al.Cancer Research Communications|March 27, 2023
Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell CarcinomaAnni I Soikkeli, Minna K Kyläniemi, Harri Sihto, et al.Cancer Research Communications|March 27, 2023
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone DestructionDavid C Florian, Natalie E Bennett, Mateusz Odziomek, et al.Cancer Research Communications|March 27, 2023
A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent GlioblastomaDaniel Chiu, Jingjing Qi, Tin Htwe Thin, et al.Cancer Research Communications|March 27, 2023
Complex Patterns of Genomic Heterogeneity Identified in 42 Tumor Samples and ctDNA of a Pulmonary Atypical Carcinoid PatientTamsin J Robb, Peter Tsai, Sandra Fitzgerald, et al.Pageof 102